FDA approves Teva's generic eltrombopag olamine tablets in three strengths
Teva Pharms USA received original approval for an ANDA covering eltrombopag olamine tablets.
The FDA's drug approval records show one item for this company during the period.
- Eltrombopag olamine, an oral tablet, received original ANDA approval under application number ANDA209938. The submission was approved with a standard review priority and a submission status date of 2026-07-13.1 The approved products include tablet strengths equivalent to 25MG, 75MG, and 12.5MG acid.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.